Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis Elbaz

Showing results (91-100 of 202) with videos related to

Pageof 21
Sort By:
Journal of Psychiatric Research|October 29, 2013
Subjective cognitive complaints and mortality: does the type of complaint matter?Archana Singh-Manoux, Aline Dugravot, Joel Ankri, et al.
Neurology|May 17, 2023
Association of Physical Activity and Parkinson Disease in Women: Long-term Follow-up of the E3N Cohort StudyBerta Portugal, Fanny Artaud, Isabelle Degaey, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 18, 2011
The relation between type of farming and prevalence of Parkinson's disease among agricultural workers in five French districtsFrédéric Moisan, Johan Spinosi, Jean-Luc Dupupet, et al.
Maturitas|February 11, 2023
Characteristics of reproductive history, use of exogenous hormones and walking speed among women: Data from the CONSTANCES French Cohort StudyMaryline Le Noan-Lainé, Fanny Artaud, Aude Laetitia Ndoadoumgue, et al.
Neurology|January 21, 2018
Smoking and Parkinson disease: Evidence for gene-by-smoking interactionsPei-Chen Lee, Ismaïl Ahmed, Marie-Anne Loriot, et al.
BMJ (Clinical Research Ed.)|January 7, 2012
Timing of onset of cognitive decline: results from Whitehall II prospective cohort studyArchana Singh-Manoux, Mika Kivimaki, M Maria Glymour, et al.
Psychosomatic Medicine|July 4, 2012
Neuroticism and cardiovascular disease mortality: socioeconomic status modifies the risk in women (UK Health and Lifestyle Survey)Gareth Hagger-Johnson, Beverly Roberts, David Boniface, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 12, 2002
Case-control study of estrogen receptor gene polymorphisms in Parkinson's diseaseDemetrius M Maraganore, Matthew J Farrer, Shannon K McDonnell, et al.
Stroke|June 4, 2016
Postmenopausal Hormone Therapy and Risk of Stroke: Impact of the Route of Estrogen Administration and Type of ProgestogenMarianne Canonico, Laure Carcaillon, Geneviève Plu-Bureau, et al.
American Journal of Epidemiology|May 25, 2011
Prediction model of Parkinson's disease based on antiparkinsonian drug claimsFrédéric Moisan, Véronique Gourlet, Jean-Louis Mazurie, et al.
Pageof 21

Showing results (91-100 of 202) with videos related to

Sort By:
Pageof 21
Journal of Psychiatric Research|October 29, 2013
Subjective cognitive complaints and mortality: does the type of complaint matter?Archana Singh-Manoux, Aline Dugravot, Joel Ankri, et al.
Neurology|May 17, 2023
Association of Physical Activity and Parkinson Disease in Women: Long-term Follow-up of the E3N Cohort StudyBerta Portugal, Fanny Artaud, Isabelle Degaey, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 18, 2011
The relation between type of farming and prevalence of Parkinson's disease among agricultural workers in five French districtsFrédéric Moisan, Johan Spinosi, Jean-Luc Dupupet, et al.
Maturitas|February 11, 2023
Characteristics of reproductive history, use of exogenous hormones and walking speed among women: Data from the CONSTANCES French Cohort StudyMaryline Le Noan-Lainé, Fanny Artaud, Aude Laetitia Ndoadoumgue, et al.
Neurology|January 21, 2018
Smoking and Parkinson disease: Evidence for gene-by-smoking interactionsPei-Chen Lee, Ismaïl Ahmed, Marie-Anne Loriot, et al.
BMJ (Clinical Research Ed.)|January 7, 2012
Timing of onset of cognitive decline: results from Whitehall II prospective cohort studyArchana Singh-Manoux, Mika Kivimaki, M Maria Glymour, et al.
Psychosomatic Medicine|July 4, 2012
Neuroticism and cardiovascular disease mortality: socioeconomic status modifies the risk in women (UK Health and Lifestyle Survey)Gareth Hagger-Johnson, Beverly Roberts, David Boniface, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 12, 2002
Case-control study of estrogen receptor gene polymorphisms in Parkinson's diseaseDemetrius M Maraganore, Matthew J Farrer, Shannon K McDonnell, et al.
Stroke|June 4, 2016
Postmenopausal Hormone Therapy and Risk of Stroke: Impact of the Route of Estrogen Administration and Type of ProgestogenMarianne Canonico, Laure Carcaillon, Geneviève Plu-Bureau, et al.
American Journal of Epidemiology|May 25, 2011
Prediction model of Parkinson's disease based on antiparkinsonian drug claimsFrédéric Moisan, Véronique Gourlet, Jean-Louis Mazurie, et al.
Pageof 21